NIDA's 2018 Avant-Garde awards highlight immune response and killer cells

(NIH/National Institute on Drug Abuse) With diverse proposals focused on everything from natural killer cells to therapeutic vaccines to treat HIV, three recipients have been selected for the 2018 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse, part of the National Institutes of Health. The awards will each provide $500,000 per year for up to five years (subject to the availability of funds) to support the research of three scientists, Drs. Catherine Blish, Nathaniel Landau, and Sara Sawyer.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news